2007
DOI: 10.1021/jm0613471
|View full text |Cite
|
Sign up to set email alerts
|

Empirical Regioselectivity Models for Human Cytochromes P450 3A4, 2D6, and 2C9

Abstract: Cytochromes P450 3A4, 2D6, and 2C9 metabolize a large fraction of drugs. Knowing where these enzymes will preferentially oxidize a molecule, the regioselectivity, allows medicinal chemists to plan how best to block its metabolism. We present QSAR-based regioselectivity models for these enzymes calibrated against compiled literature data of drugs and drug-like compounds. These models are purely empirical and use only the structures of the substrates, in contrast to those models that simulate a specific mechanis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
134
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(136 citation statements)
references
References 21 publications
2
134
0
Order By: Relevance
“…for predicting sites of metabolism on the substrate, have been based on mechanistic information relating to the substrate-enzyme interaction. An alternative approach, entirely QSAR-based and not simulating specific mechanisms and/or using explicit models of active sites, was proposed by Sheridan et al (2007) for predicting CYP450 (3A4, 2D6, 2C9) sites of the metabolism The model was based on a dataset consisting of 532 diverse molecules (316 for CYP3A4, 124 for CYP2D6, and 92 for CYP2C9), collected mainly from the literature, but including also some proprietary in-house data. An external test set of 25 compounds was also used.…”
mentioning
confidence: 99%
“…for predicting sites of metabolism on the substrate, have been based on mechanistic information relating to the substrate-enzyme interaction. An alternative approach, entirely QSAR-based and not simulating specific mechanisms and/or using explicit models of active sites, was proposed by Sheridan et al (2007) for predicting CYP450 (3A4, 2D6, 2C9) sites of the metabolism The model was based on a dataset consisting of 532 diverse molecules (316 for CYP3A4, 124 for CYP2D6, and 92 for CYP2C9), collected mainly from the literature, but including also some proprietary in-house data. An external test set of 25 compounds was also used.…”
mentioning
confidence: 99%
“…Sheridan et al used the random forest (RF) method, and their descriptors included structural descriptors, SASA and topological descriptors to develop SOM prediction models for CYP3A4, 2D6, and 2C9. The predictive power of this model is comparable with that of MetaSite (Sheridan et al 2007). Zheng et al calculated quantum chemical descriptors to characterize atom reactivity and used the SVM method to develop six CYP SOM prediction models for major metabolic reaction types.…”
Section: Som Predictionmentioning
confidence: 61%
“…6 The fact that the enzyme induces the binding suggests that it is relevant to use the protein structures to predict how drug compounds are metabolized. This is probably why only few studies of pure ligand-based models on SOM prediction for CYP2D6 exist, 7 and structural information of protein has been included for these purposes. de Groot and co-workers combined structural models of CYP2D6 and pharmacophore modeling with AM1 energies of intermediates and products to predict the SOMs.…”
Section: * S Supporting Informationmentioning
confidence: 99%